The 18 references in paper A. Smirnov V., I. Trofimenko I., А. Смирнов В., И. Трофименко И. (2010) “ПРАКТИЧЕСКИЕ ВОПРОСЫ ПРИМЕНЕНИЯ ЦИКЛОСПОРИНА В ЛЕЧЕНИИ ГЛОМЕРУЛОПАТИЙ // PRACTICAL ISSUES OF CYCLOSPORINE IN THE TREATMENT OF GLOMERULOPATHY” / spz:neicon:nefr:y:2010:i:4:p:96-102

1
Смирнов АВ. Лечение гломерулопатий циклоспори­ ном. Правильный подход с неверным обоснованием. Не­ фрология 2010; 14 (4): 9-22
(check this in PDF content)
2
Alexopoulos E, Papagianni A, Tsamelashvili M et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006; 21 (11): 3127-3132
(check this in PDF content)
3
Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 2007; 72 (12): 1429-1447
(check this in PDF content)
4
Goumenos DS, Katopodis KP, Passadakis P et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol 2007; 27 (3): 226-231
(check this in PDF content)
5
Ehrich JH, Geerlings C, Zivicnjak M et al. Steroid- resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 2007; 22 (8): 2183-2193
(check this in PDF content)
6
Goumenos DS. What have we learned from the use of cyclosporine A in the treatment of nephrotic patients with idiopathic membranous nephropathy? Expert Opin Pharmacother 2008; 9(10): 1695-1704
(check this in PDF content)
7
Braun N, Schmutzler F, Lange C et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16 (3): CD003233
(check this in PDF content)
8
Захарова ЕВ, Бирюкова ЛС. Роль циклоспорина в лечении идиопатического гломерулонефрита и волчаноч­ ного нефрита. Нефрология и диализ 2010; 12(2): 126-141
(check this in PDF content)
9
Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose, Shannon MW, Borron SW, Burns MJ 4th ed., 2007; Saunders,1584
(check this in PDF content)
10
Masuda S, Inui K. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112(1): 184-198
(check this in PDF content)
11
Robert N, Wong GWK, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007893
(check this in PDF content)
12
Kelley’s Textbook of Rheumatology, Ed. Firestein GS, Budd RC, Harris ED,et al. 8th ed., Saunders, 2064
(check this in PDF content)
13
Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant 2006; 21(8): 2060-2063
(check this in PDF content)
14
Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4(2): 481-508
(check this in PDF content)
15
Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol 2007; 67(6): 335-340
(check this in PDF content)
16
Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med 2009; 24(2): 81-92
(check this in PDF content)
17
Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56 (6): 2220-2226
(check this in PDF content)
18
Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20(3): 268-287 Поступила в редакцию 18.10.2010 г. Принята в печать 17.11.2010 г.
(check this in PDF content)